Skip to main content
Premium Trial:

Request an Annual Quote

Strata Oncology: Sundu Brahmasandra

Strata Oncology appointed Sundu Brahmasandra as chief operating officer. Brahmasandra previously served as president and COO of NeuMoDx Molecular, and later as vice president and head of operations and product management at Qiagen, after that company acquired NeuMoDx. He also cofounded HandyLab, a developer and manufacturer of molecular diagnostic assays and automation platforms, which was acquired by BD Diagnostics, where he then served as vice president of R&D assay development. 

Brahmasandra holds a PhD in chemical engineering from the University of Michigan College of Engineering and a bachelor's degree in chemical engineering from the Indian Institute of Technology, Madras.